News
4317 posts · page 124 of 180
Molbio Diagnostics Eyes ₹940 Crore Through IPO for Expansion
Molbio Diagnostics plans a ₹940 crore IPO to fund capital expenditures and reduce promoter stake, aiming for long-term growth despite high-risk investment.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests 9.9% of Thyrocare, lowering its stake to 51.02%. The sale attracted major institutional investors.
Surrogate Battles for Custody After Birth Amid Legal Conflict
A surrogate mother is embroiled in a custody battle after giving birth to a baby diagnosed with a heart defect.
Medical Device Industry Challenges India's Draft Regulatory Bill
Medical device firms argue against India's draft bill aligning devices with pharma, citing potential harm to innovation.
Abhay Soi Criticizes Proposed Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi argues against a price cap on hospital rooms, citing investment concerns.
Molbio Diagnostics Targets ₹940 Crore in IPO to Boost Growth
Molbio Diagnostics seeks ₹940 crore through IPO to fund expansion and reduce promoter stake.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests 9.9% of Thyrocare, reducing its stake to 51.02%. Major investors included HSBC and Morgan Stanley.
Surrogate Birth Triggers Legal Battle Over Child Custody
A surrogate in Texas gave birth amid a legal dispute after biological parents requested pregnancy termination.
Medical Device Firms Challenge Pharmaceutical-Like Regulations
India's medical device sector opposes a draft bill equating devices with drugs, citing potential harm to innovation and investment.
Abhay Soi Challenges Proposed Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi urges reconsideration of a price cap, citing investment needs.
Molbio Diagnostics Eyes ₹940 Crore IPO to Fuel Global Expansion
Molbio Diagnostics plans a ₹940 crore IPO to boost capital and reduce promoter stake, aiming for growth in global diagnostics markets.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests 9.9% of Thyrocare, raising Rs 986 crore through bulk and block deals.
Surrogate Birth Sparks Legal Battle Over Child Custody
A surrogate in Texas is fighting for custody after giving birth amid a legal dispute with the biological parents.
Medical Device Sector Pushes Back Against India's Draft Bill
Industry leaders argue the 2026 draft bill could stifle innovation by treating devices as pharma products.
Abhay Soi Challenges Price Cap Proposal for Private Hospitals
Max Healthcare's Abhay Soi warns a blanket price cap on hospital rooms could hinder investments.
Maharashtra Partners with Global Leaders to Develop NMIMC
Maharashtra joins forces with Cleveland Clinic, Brookfield, and Arodhan Health City to establish the NMIMC, a new healthcare facility.
Exploring the Health Benefits of Lemon Juice: What You Need to Know
Lemon juice offers several health benefits, from boosting immunity to aiding digestion. Discover six key advantages and how to incorporate it into your diet.
Suvi Health Unveils AI to Shorten Hospital Stays, Ease Care Transitions
Suvi Health introduces an AI tool aimed at reducing hospital stays and enhancing patient care transitions.
AI's Potential to Democratize Mayo Clinic-Level Healthcare
AI could extend top-tier healthcare like Mayo Clinic's to a broader population, enhancing accessibility and efficiency.
Proactive Health: Strategies for Personal Wellness Management
Mayo Clinic Press offers strategies for individuals to take charge of their health, emphasizing preventive care and informed decision-making.
North Carolina A&T Secures $16.9M for Health Disparities Research Center
North Carolina A&T University receives $16.9M from NIH to establish a research center tackling health disparities.
NIH Pediatric Research Funding Sees Notable Shifts from 2015 to 2024
NIH funding for pediatric research has seen significant changes, highlighting shifts in focus and priorities over the past decade.
NIH Advances Parkinson’s Treatment with New Initiatives
The NIH unveils new strategies to enhance therapies for Parkinson’s, aiming to improve patient outcomes.
Molbio Diagnostics IPO: A High-Risk Bet on Long-Term Growth?
Molbio Diagnostics seeks ₹940 crore through IPO for capital expansion and promoter stake reduction.